Ken Griffin Biomerica Inc Put Options Transaction History

Citadel Advisors LLC

  • $483 Billion
  • Q2 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024
BUY
$0.82 - $1.29 $82 - $129
100 New
100 $0
Q2 2023

Aug 14, 2023
SELL
$1.12 - $1.87 $9,408 - $15,708
-8,400 Reduced 98.82%
100 $0
Q1 2023

May 15, 2023
BUY
$1.86 - $3.56 $9,114 - $17,444
4,900 Added 136.11%
8,500 $15,000
Q4 2022

Feb 14, 2023
BUY
$2.98 - $4.17 $10,728 - $15,012
3,600 New
3,600 $12,000

Others Institutions Holding BMRA

# of Institutions
36
Shares Held
2.38M
Call Options Held
0
Put Options Held
0
View Full List

About BIOMERICA INC

BMRA Quotes by TradingView
  • Ticker BMRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 13,427,700
  • Market Cap $4.97M
  • Description
  • Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various disea...
More about BMRA
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email